WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Anti-aging startup NewLimit raises $435M at $3B+ valuation, eyes clinic in 2027

NewLimit said Tuesday it has raised a $435 million Series C round at a $3.1 billion post-money valuation.

Raccontata dastatnews.comendpoints.newscryptobriefing.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
endpoints.newsStai leggendo6 h fa

Anti-aging startup NewLimit raises $435M at $3B+ valuation, eyes clinic in 2027

NewLimit said Tuesday it has raised a $435 million Series C round at a $3.1 billion post-money valuation.

originale
cryptobriefing.com3 h fa

NewLimit triples valuation to $3B with $435M funding round

NewLimit, co-founded by Coinbase CEO Brian Armstrong, raises $435M at a $3.1B valuation for its epigenetic reprogramming approach to reversing aging.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 2 giugno 2026·statnews.com

    Longevity startup NewLimit raises $435 million ahead of first clinical trial

    Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.

  2. martedì 2 giugno 2026·endpoints.news

    Anti-aging startup NewLimit raises $435M at $3B+ valuation, eyes clinic in 2027

    NewLimit said Tuesday it has raised a $435 million Series C round at a $3.1 billion post-money valuation.

statnews.com6 h fa

Longevity startup NewLimit raises $435 million ahead of first clinical trial

Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.

Leggi questa versione → originale
  • martedì 2 giugno 2026·cryptobriefing.com

    NewLimit triples valuation to $3B with $435M funding round

    NewLimit, co-founded by Coinbase CEO Brian Armstrong, raises $435M at a $3.1B valuation for its epigenetic reprogramming approach to reversing aging.